shengxuening

Networked: 6 relevant articles (1 outcomes, 2 trials/studies)

1.	Anemia 07/01/2016 - "In conclusion, Shengxuening tablet combined with rHuEPO was safe and effective for the treatment of renal anemia of MHD patients." 01/01/2022 - "Shengxuening Tablet (SXN) has been used for the treatment of various types of anemia, attaining high efficacy. " 12/01/2020 - "Shengxuening versus Oral Iron Supplementation for the Treatment of Renal Anemia: A Systematic Review." 10/01/2016 - "Effect and safety of Shengxuening (extract from excrement of bombyxin) for renal anemia: a systematic review." 07/01/2016 - "Clinical study of Shengxuening tablet combined with rHuEPO for the treatment of renal anemia of maintenance hemodialysis patients."
2.	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 10/01/2004 - "[Study on treatment of iron-deficiency anemia by shengxuening]." 01/01/2022 - "The efficiency and safety of Shengxuening tablet on treating and preventing iron deficiency anemia: A systematic review and meta-analysis." 10/01/2004 - "To observe the therapeutic effect of shengxuening (SXN) in treating iron-deficiency anemia (IDA) and to explore its molecular mechanism on iron metabolism balance regulation. "
3.	Aplastic Anemia (Anemia, Hypoplastic) 06/01/2006 - "Clinical observation on treatment of chronic aplastic anemia by Shengxuening and cyclosporin A."

1.	Renal Dialysis (Hemodialysis)